Katherine Szarama Appointed Acting Head of FDA Vaccines Unit

New Leadership at the FDA#

The U.S. Food and Drug Administration (FDA) has appointed Katherine Szarama as the acting director of its Center for Biologics Evaluation and Research. This center is responsible for overseeing vaccines, gene therapies, and the blood supply. Szarama's appointment comes after the recent departure of Vinay Prasad, who ended his tenure at the agency this week.

Transition in Management#

FDA Commissioner Marty Makary announced that a permanent successor to Prasad has not yet been chosen. An official announcement regarding a permanent appointment is expected in the coming weeks. This transition period is crucial as the center plays a significant role in public health, particularly in the context of vaccines and treatments.

Background on Vinay Prasad#

Vinay Prasad, an oncologist, was known for his outspoken views on U.S. drug and vaccine policies, especially concerning COVID-19 mandates. His time at the FDA included several notable decisions related to rare disease drugs and vaccines, reflecting the complexities and challenges faced by the agency in managing public health initiatives.